Absci Corporation
ABSINASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $1.40B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $2.24$12.06
- Volume (live)
- -
- Avg. volume (3M)
- 4.02M
Absci (ABSI) Stock Price & Financial Analysis
Absci Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $8.12 - $8.95 |
|---|---|
| 52-Week High | $12.06 |
| 52-Week Low | $2.24 |
| Open | $8.93 |
| Volume (last close) | 3.53M |
| Average Volume (3M) | 4.02M |
| Revenue (TTM) | 1.56M |
|---|---|
| Net Income (TTM) | -121.08M |
| Free Cash Flow (TTM) | -108.97M |
| EPS (TTM) | −$0.80 |
| Profit Margin | -7756.37% |
| Operating Margin | -8411.27% |
| Return on Equity (ROE) | -49.19% |
| Debt to Equity | 0.01 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 1.40B |
|---|---|
| Shares Outstanding | 157.47M |
| Price to Sales (P/S) | 895.80 |
| Price to Book (P/B) | 5.68 |
| EV/EBITDA | -11.65 |
| 50-Day MA | $9.33 |
|---|---|
| 200-Day MA | $6.11 |
| 1-Year Change | +96.03% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Absci at a Glance
As of the Oct 16, 2026 close, Absci (ABSI) has a market capitalization of $1.40B. The stock trades at 895.8× sales. Over the trailing twelve months it lost $121.08M on revenue of $1.56M and burned $108.97M of free cash flow. Revenue fell 62.3% year over year.
As of its latest reported balance sheet, it holds $107.86M in cash and securities against $1.79M of debt, a net cash position of $106.07M.
Absci does not currently pay a dividend.
The share price is up 96.0% over the past year. At $8.25 (the Oct 16, 2026 close) it sits within its 52-week range of $2.24 to $12.05, above its 200-day moving average of $6.11.
Based on 8 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $13.67, 65.7% above the Oct 16, 2026 close.
Frequently Asked Questions About Absci
What is the current stock price for ABSI?
As of the Oct 16, 2026 close, ABSI stock trades at $8.25. The 52-week range is $2.24–$12.06, with a day range of $8.12–$8.95.
What is the P/E ratio for ABSI?
The P/E ratio (Price-to-Earnings) for ABSI is shown in the Key Statistics section. This valuation metric helps compare Absci Corporation to industry peers.
Does ABSI pay dividends?
Absci does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for ABSI?
Based on ratings from 8 professional analysts over the last 90 days, the consensus for ABSI is Buy. The average 12-month price target is $13.67, a 65.7% upside from the Oct 16, 2026 close of $8.25.
What is the market cap of ABSI?
As of the Oct 16, 2026 close, Absci's market capitalization is $1.30B, classifying it as a small-cap company. Absci operates in the Healthcare sector within the Biotechnology industry.